A Primer on Using Third-Party Depositions To Prove Your Case at Trial
The decision for deposing a nonparty presents a Rubik’s cube of factors that need to be considered holistically to best prepare for trial.
Polyrizon Commences GMP Manufacturing Preliminary Process for its PL-14 Allergy Blocker in Preparation for Planned 2025 Clinical Trial
Eurofins CDMO Amatsiaquitaine S.A.S., the GMP manufacturer, to support Polyrizon in future commercialization effortsRaanana, Israel, Jan. 23, ...
Compoundsemiconductor.net3d
P-GaN gate HEMTs have record threshold voltage
Researchers at Shandong University in China have reported an enhancement-mode P-GaN/AlGaN/GaN metal-insulator-semiconductor ...
Oilsands pollution study reveals new 'blind spot' in industry reporting
New research has found that a complex form of air pollution from Alberta's oilsands has gone largely unreported — and the ...